Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
5.192 EUR | -2.22% | -0.27% | -16.58% |
Nov. 27 | Ema Accepts Valneva?s Chikungunya Vaccine Marketing Authorization Application for Accelerated Assessment | CI |
Nov. 27 | CAC40: declines at the end of the session, penalized by Thalès | CF |
Chart calendar Valneva SE
8397db6709651ca82626b61c2e.2b_Yp49ZqNVSIanuTUKkVoWrJyOZ4MqbelvgyNKhVLQ.voaP06I8mpYTUf2qAwzXMOThQELtiIO2Mz-jn73LMt-BiojGtwn5hidl7A~6855b98e39d61cc1f1f8acf53a82d388
Upcoming events on Valneva SE
Past events on Valneva SE
2023-11-14 09:30 am | Jefferies London Healthcare Conference |
2023-11-13 09:00 am | IXCHIQ FDA Approval Call |
2023-11-11 | International Society for Pharmacoeconomics and Outcomes Research European Congress |
2023-11-09 09:00 am | Q3 2023 Earnings Call |
2023-11-09 01:00 am | Q3 2023 Earnings Release |
2023-10-24 03:45 am | International Society of Vaccines Congress |
2023-10-20 01:15 pm | American Society of Tropical Medicine and Hygiene Meeting |
2023-10-20 12:00 pm | American Society of Tropical Medicine and Hygiene Meeting |
2023-10-15 | World Vaccine Congress |
2023-10-15 | World Vaccine Congress |
2023-10-14 06:00 pm | Infectious Diseases Society of America Meeting |
2023-09-21 09:00 am | Q2 2023 Earnings Call |
2023-09-21 01:00 am | Q2 2023 Earnings Release |
2023-09-11 | Kepler Cheuvreux Autumn Conference |
2023-09-11 | H.C. Wainwright Global Investment Conference |
2023-09-10 | Morgan Stanley Global Healthcare Conference |
2023-06-27 | Stifel European Healthcare Summit |
2023-06-21 08:00 am | Annual General Meeting |
2023-06-11 | Goldman Sachs Global Healthcare Conference |
2023-06-07 01:30 pm | Jefferies Global Healthcare Conference |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 113 113 0.08% | 126 124 1.84% | 110 121 -8.96% | 348 103 237.38% | 361 342 5.67% | 190 |
EBITDA Million EUR | Released Forecast Spread | 13,1 8,68 50.96% | 7,80 10,6 -26.16% | -45,2 -42,9 -5.26% | -47,1 -31,6 -48.94% | -69,2 -30,3 -128.36% | 10,5 |
EBIT Million EUR | Released Forecast Spread | 6,30 0,26 2306.42% | -0,81 1,73 -146.99% | -55,1 -52,7 -4.61% | -61,4 -63,7 3.55% | -113 -33,8 -235.21% | 6,50 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 3,35 -4,87 168.78% | -0,87 -3,96 78.01% | -65,3 -64,1 -1.95% | -70,0 55,6 -225.97% | -145 -84,4 -71.58% | -30,7 |
Net income Million EUR | Released Forecast Spread | 3,30 -4,62 171.42% | -1,70 -4,87 65.1% | -64,4 -62,7 -2.74% | -73,4 -64,3 -14.14% | -143 -85,4 -67.77% | -1,35 |
EPS EUR | Released Forecast Spread | 0,04 -0,05 176.19% | -0,02 -0,05 56.1% | -0,71 -0,69 -3.5% | -0,75 -0,61 -22.95% | -1,24 -0,59 -110.17% | 0,05 |
Announcement Date | 02/21/19 | 02/27/20 | 02/25/21 | 02/03/22 | 03/23/23 | - |
Quarterly results
Fiscal Period | December | 2020 S1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 47,9 72,5 -33.92% | 24,3 23,5 3.57% | 22,3 19,8 12.51% | 278 26,9 934.85% | 21,8 22,6 -3.57% | 71,4 21,4 232.96% | 93,2 45,3 105.69% | 157 116 34.81% | 111 90,0 23.73% | 33,5 30,4 10.29% | 40,2 33,1 21.5% | 38,1 41,4 -8.06% | 96,5 |
EBITDA Million EUR | Released Forecast Spread | -42,6 | 12,5 -31,8 139.43% | -13,3 -48,7 72.69% | -123 -43,0 -185.35% | -5,20 | ||||||||
EBIT Million EUR | Released Forecast Spread | -21,9 -9,20 -138.35% | -55,1 -38,3 -44.05% | -151 64,7 -334.02% | 11,1 -37,2 129.87% | -18,4 -69,6 73.56% | -129 -45,2 -185.02% | -147 -98,9 -48.8% | 93,3 36,2 158.09% | -56,4 34,9 -261.4% | -16,6 -21,5 22.8% | -20,3 -18,4 -9.98% | -22,2 -22,5 1.16% | 74,0 |
EPS EUR | Released Forecast Spread | -0,13 -0,14 7.14% | -0,12 -0,13 7.69% | -0,25 -0,12 -108.33% | 0,53 | |||||||||
Announcement Date | 08/04/20 | 08/10/21 | 11/18/21 | 02/03/22 | 05/05/22 | 08/11/22 | 08/11/22 | 11/10/22 | 03/23/23 | 05/04/23 | 09/21/23 | 11/09/23 | - |
2024-01-22 | Q3 2024 Earnings Release (Projected) |
2024-01-23 | Q4 2023 Earnings Release (Projected) |
2024-01-31 | Q3 2023 Earnings Release (Projected) |
2024-02-02 12:45 am | Q4 2023 Earnings Release |
2024-02-05 | Q1 2024 Earnings Release (Projected) |
2024-02-05 | Q2 2024 Earnings Release (Projected) |
2024-02-05 | Q4 2023 Earnings Release (Projected) |
2024-02-06 | Q1 2024 Earnings Release (Projected) |
2024-02-07 | Q4 2023 Earnings Release (Projected) |
2024-02-07 | Q4 2023 Earnings Release (Projected) |
Past sector events for Valneva SE
2023-11-28 04:15 pm | Q3 2023 Earnings Release |
2023-11-15 | Q3 2023 Earnings Release (Projected) |
2023-11-15 04:01 pm | Q3 2023 Earnings Release |
2023-11-14 04:05 pm | Q3 2023 Earnings Release |
2023-11-14 04:01 pm | Q3 2023 Earnings Release |
2023-11-14 07:00 am | Q3 2023 Earnings Release |
2023-11-14 06:30 am | Q3 2023 Earnings Release |
2023-11-13 | Q3 2023 Earnings Release |
2023-11-13 08:15 pm | Q3 2023 Earnings Release |
2023-11-13 04:07 pm | Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Valneva SE - Euronext Paris
- Calendar Valneva SE